TSANZ home

Results for "cough"

Home 5 Search query for: cough
Results for "cough"

TSANZ Research Medal Presentations

TSANZ Research Medal Presentations

Date Recorded: 28th July 2020

Duration: Approx. 1 Hour

The Research Medal may be awarded each year in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in their field of research.

TSANZ Research Medal Winners 2020:

Professor Shyamali Dharmage

Title of talk:
Pre-COPD: where are we and where to from here?

BIO
Prof Dharmage has been formerly trained in Medicine, Public Health and Epidemiology. She conceived and developed the Melbourne University Allergy and Lung Health Unit that is at the forefront of the research into environmental and genetic risk factors for and biological pathways of chronic respiratory diseases. She is the PI of two of the world’s key longitudinal studies in lung health, the Tasmanian Longitudinal Health Study and the Melbourne Atopy Family Cohort Study. She is also the PI of the Australian Centre of RHINESA, a three generation international study of asthma and Australian Centre of Ageing Lungs in European Cohorts (ALEC). She has secured over 60 million Australian Dollars for her research program and published over 400 peer reviewed articles including in Lancet, Lancet Respiratory Medicine, Nature Genetics, American Journal of Respiratory and Critical Care Medicine, and BMJ. She has been on a number of editorial boards including her current positions in Clinical and Experimental Allergy and Lancet Respiratory Medicine. Her current interests include lifetime lung function and asthma trajectories and transgenerational risk factors for poor lung health.

Professor Alan James

Title of talk:
Defining Airway Disease Phenotypes for Clinical Use

BIO
Alan James is a consultant respiratory physician and clinical scientist at Sir Charles Gairdner Hospital, Hollywood Private Hospital and the University of Western Australia in Perth, Western Australia. He and his research team are studying mechanisms of excessive airway narrowing in asthma, particularly the roles of increased smooth muscle and matrix and how to measure them, with a view to new treatments. As Chair of the Busselton Health Study he also leads research teams studying healthy ageing and the characteristics of airway disease such as asthma, cough, COPD, airway inflammation and altered airway structure in the general population. These studies aim to improve appropriate management of airway diseases at the primary care level. He has published over 250 journal articles, book chapters and editorials and in 2017 received the Asia Pacific Society of Respirology Ann Woolcock Research Medal.

Registration:

To register your interest in the on-demand recording, please register below. You will then be sent an e-mail, allowing you to obtain the recording links through Vimeo.

Category Fee (excl. GST)
TSANZ Members Free
Non-members $20

Require assistance?

Please contact the TSANZ Office on +61 2 9222 6200 or e-mail tsanzeducation@thoracic.org.au

VOLUME 5.03 – APRIL 2020

VOLUME 5.03 – APRIL 2020

Research Roundup:

April 2020

.

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. We currently have two invitations on offer – one for a study in Identifying barriers and facilitators to the implementation of best practice for pulmonary fibrosis in Australia, the other for participation in the ASCOT trial.

Submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. You will be featured in an upcoming Research Roundup and also published on the limbic website. This is a great opportunity to tell us about your research and inspiration, and provides a platform to be able to connect your passion project with our network of TSANZ members and the limbic subscribers. Details can be found here.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the March edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

Respirology – Editor’s Choice 

Respirology Issue 25.4 April 2020

 

We won’t find what we don’t look for: Identifying barriers and enablers of chronic wet cough in Aboriginal children

Pamela Laird, Roz Walker, Mary Lane, Anne B. Chang and Andre Schultz

 

DOI: 10.1111/resp.13642

 

Obesity hypoventilation syndrome treated with non-invasive ventilation: Is a switch to CPAP therapy feasible?

Maria P. Arellano-Maric, Christine Hamm, Marieke L. Duiverman, Sarah Schwarz, Jens Callegari, Jan H. Storre, Claudia Schmoor, Marc Spielsmanns, Wolfgang Galetke and Wolfram Windisch

 

Principal investigator Maria Paola Arellano-Maric, MD (left) and senior investigator Prof. Dr. Wolfram Windisch (right)

DOI: 10.1111/resp.13704

ASCOT Trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

 

Protocol documents and further details are available at www.ascot-trial.edu.au

Invitation

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland

Professor of Physiotherapy, Monash University and Alfred Health

Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University

Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 5.03 – APRIL 2020

VOLUME 4.010 – DECEMBER 2019

Research Roundup:

December 2019

.
 

Welcome Message

As the year draws to a close and many of us are wrapping up for the summer break we have a few short messages for you.

Firstly, we have three awards open which we would like to draw your attention to:

Secondly, late-breaking abstracts are open, so if you have any new work to share with your colleagues, please consider submitting to TSANZSRS 2020!

Lastly, we wish you all a safe and relaxing break over the festive season. For those who will remain at work, we hope all goes smoothly for you! Enjoy the December edition of your research roundup and please check out the surveys below.

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

 

Thoracic Society Awards 

There are three Thoracic Society Awards open:

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Respirology – Editor’s Choice 

Respirology Issue 24.12 December 2019

 

Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD

Mette Reilev, Anton Pottegård, Jesper Lykkegaard, Jens Søndergaard, Truls S Ingebrigtsen and Jesper Hallas

 

 

DOI: 10.1111/resp.13620

Top row, from left to right: Mette Reilev, Jesper Hallas and Anton Pottegård, Clinical Pharmacology and Pharmacy, University of Southern Denmark

Bottom row, from left to right: Jesper Lykkegaard and Jens Søndergaard, The Research Unit for General Practice, University of Southern Denmark

Non-invasive ventilation versus oxygen therapy in cystic fibrosis: A 12-month randomized trial

Maree A. Milross, Amanda J. Piper, Tiffany J. Dwyer, Keith Wong, Scott C. Bell, Peter T.P. Bye and the Non-Invasive Ventilation Cystic Fibrosis (NIVCF) Study Group

Non-invasive ventilation in cystic fibrosis

DOI: 10.1111/resp.13604

Research Project and Survey Requests

 

Competitive Grants of Up To $1 Million To Turn Medical Discoveries Into Clinical Reality (Fed)

Minister for Health, Greg Hunt, says cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

EOI applications open: Tuesday, 15 October 2019.
Closing Date: Monday, 16 December 2019

Click here for further details

Workshops and Conferences

 

Chronic Breathlessness

 

The Australian national Palliative Care Clinical Studies Collaborative (PaCCSC) is pleased to announce the publication of results from a recently completed multi-site, double-blind, randomised controlled trial that found that regular, sustained-release morphine had similar benefits and harms to placebo in this adequately powered trial at one week.

The manuscript is titled “Regular, sustained-release morphine for chronic breathlessness: a multi-centre, double-blind, randomised, placebo controlled trial”. Authored by David Currow and colleagues, the paper was published in Thorax 2019; 213681 (ahead of print). A copy of the paper is attached for your benefit.

 

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 5.03 – APRIL 2020

VOLUME 4.09 NOVEMBER 2019

Research Roundup:

November 2019

.
 

Welcome Message

We are now in the penultimate month of the year, and for the Thoracic Society this sparks the beginning of the busy lead up to our national conference. The Research Sub-committee is in full swing reviewing award applications, the SIG convenors are reviewing abstract submissions, and our conference organisers are ensuring the sessions are programmed smoothly to present your research in the best way possible. For 2020, we are expecting another large conference, having received approximately 440 submissions. Details are gradually being added to the TSANZSRS site and the early program is now visible. Early bird registration is available until the 18th of January, 2020.

Thanks to the many who recently submitted award applications. We would like to highlight that a number of awards are still open and some have been extended – please look below or on our website to find out more information.

We hope you enjoy this edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

 

Thoracic Society Awards 

There are three Thoracic Society Awards open:

 

Lund Foundation Australia Research Awards 

  • Cochrane Airways Australia Scholarship – extended to 15 November 2019

To download application documents, click here.

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

TSANZ Webinar Series

 

“Tracheostomy tubes and principles of management” with Gavin Fahey

Event Date: Thursday, 14th of November 2019

Time: 2:30pm AEDT

Duration: 45 minutes

A presentation covering anatomy and physiology, tube selection, principles of nursing and emergency management.

Only limited places available! Don’t miss out!

The presenter: Gavin Fahey

Gavin Fahey currently works as Senior Respiratory Clinical Nurse Consultant (CNC) at Northern Health (NH) leading a team of Respiratory CNCs who since 2018 have collectively contributed to acquisition and management of oxygen services across NH, development of a 4-bed Respiratory Care Unit caring for patients with severe respiratory failure, and improving lung mass services incorporating development of Victoria’s first Specialist Ambulatory Pleural Service. Gavin’s experience includes working within both the Victorian Respiratory Support Service and Tracheostomy and Management Service (Austin Health) utilising his experience and advanced understanding of tracheostomy and ventilation management within the acute and outpatients setting.

CLICK HERE to register! 

_______________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars are now available for on-demand viewing. For more information, please CLICK HERE!

Respirology – Editor’s Choice

Respirology Issue 24.11 November 2019

Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial

Steven McKinstry, Joseph Singer, Jan Pieter Baarsma, Mark Weatherall, Richard Beasley, James Fingleton

DOI: 10.1111/resp.13575

Nasal High Flow therapy in use

BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo

Rebecca L. Harper, Suzanne Maiolo, Rebekah J. Ward, Jemma Seyfang, Michaelia P. Cockshell, Claudine S. Bonder, Paul N. Reynolds

Putative mechanism of cell therapy upregulating BMPR2 in pulmonary vessels via release of exosomes

DOI: 10.1111/resp.13552

Research Project and Survey Requests

 

Competitive Grants of Up To $1 Million To Turn Medical Discoveries Into Clinical Reality (Fed)

Minister for Health, Greg Hunt, says cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

EOI applications open: Tuesday, 15 October 2019.
Closing Date: Monday, 16 December 2019

Click here for further details

Workshops and Conferences

Dear TSANZ Members,

Lung Foundation Australia, with the support of nursing members of the Australia and New Zealand – Lung Cancer Nurse Forum, invite you to the next workshop in the series: Treatment Modalities and Management of a Stage 3 NSCLC Patient workshop, in Hobart on Friday 29 November 2019.

These workshops are open to nurses and allied health with an interest in working with and caring for people with lung cancer.

Date: Friday 29 November 2019

Time: 9:30am – 12:30pm

Location: Cancer Support Centre, Royal Hobart Hospital, 48 Liverpool St, Hobart TAS 7000

Program: Medical experts including nurses, medical oncology and radiation oncology specialists, and allied health professionals will discuss the management of a Stage III unresectable lung cancer patient.

More information about the agenda and speakers are coming soon. Please see our website for up to date information on this workshop.

Workshops are free to attend and you will be provided with a certificate for your hours of learning.

Register here

Please RSVP by Friday 22 November 2019. Registrations are essential for seating and catering purposes. For more information on the event, please visit our website here.

For further queries, please contact our information and support centre freecall on 1800 654 301 or email enquiries@lungfoundation.com.au.

We hope to see you on the day!

Kind Regards,

Lung Foundation Australia

 

                                                                                                                                                              

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 5.03 – APRIL 2020

VOLUME 4.07 SEPEMBER 2019

Research Roundup:

September 2019

.
 

Welcome Message

Welcome to the September Issue. Many of our current TSANZ Awards will be closing next month, following the Abstract Submission deadline for our TSANZSRS2020 ASM. Preparations are well and truly underway for the ASM so we hope to see you there and presenting your work!

If you are interested in attending the APSR Congress in November, we have one LFA A/Menarini Travel Award closing on 13 September to sponsor those researching or involved in COPD.

Submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. If you have been trying to uncover some hidden academic riches locked away in the recesses of respiratory research, we want to hear about it! You will be featured in an upcoming Research Roundup and also published on the limbic website. This is a great opportunity to tell us about your research and inspiration, and provides a platform to be able to connect your passion project with our network of TSANZ members and the limbic subscribers. Details can be found here.

Lastly, please support the research of TSANZ members and supporters by contributing to the surveys at the end of this newsletter.

We hope you enjoy this edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ ASM 2020 abstract-linked Awards – closing 11 October 2019

TSANZ Indigenous Respiratory Nursing Award – closes 30th October 2019

TSANZ Peter Phelan Research Award – closes 30th October 2019

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 30th October 2019

Lung Foundation Awards

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards APSR closing 13th September 2019 (5pm AEST)

Lung Foundation Australia / Brian Eaton PhD IPF Scholarship 2019EXTENDED closing date 30 October 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Respirology – Editor’s Choice 

Respirology Issue 24.9 September 2019

Special Issue on Pulmonary Fibrosis Awareness Month

 

In support of Pulmonary Fibrosis Awareness month September, Respirology offers free access to selected articles during the month of September 2019.
The articles will be available at
https://onlinelibrary.wiley.com/page/journal/14401843/pf-awareness-month-2019

Research Project and Survey Requests

Dear TSANZ Members,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice in regards to Advance Care Planning in patients with chronic obstructive pulmonary disease (COPD). 

This study is being conducted by:
Ms Mary Roberts, Dr Tracy Smith, Professor Wheatley and Dr Jin-Gun Cho. Details and affiliations of the research team can be obtained by contacting Ms Mary Roberts by phone 0408 490 371 or email mary.roberts@health.nsw.gov.au

The results of the survey will form part of a research project with the aim to develop resources to improve the quality and uptake of advanced care planning in patients with COPD. This survey has been approved by the WSLHD HREC under authorisation number 5990 2019/ETH00197.

The estimated time to complete the survey is 10-15 minutes. If you exit out the survey early or don’t click DONE on the final page, your responses will not be saved. You may skip questions if you wish, though we would prefer you didn’t.  

Your participation is voluntary and anonymous. Your contribution is greatly appreciated.
We thank you in advance for your participation.
Here is the link: https://www.surveymonkey.com/r/8S6TLF6

Sincerely,

Ms MM Roberts

Mary Roberts

Clinical Nurse Consultant | Respiratory Ambulatory Care

Clinical Lecturer, Sydney Medical School, University of Sydney

 

Determining a Patient-Centred Model of Care in Severe Asthma: What can we learn from the views, needs, and challenges of Clinicians’ and Carers of people with Severe Asthma and COPD?

Phase 1- Clinicians’ group

Investigators: Dr Vanessa Clark, Professor Vanessa McDonald, Professor Peter Gibson, and Eleanor Majellano

Invitation

You are invited to participate in a research study that explores the barriers and facilitators to the optimal management of severe asthma. This research is being conducted as part of the requirements for a PhD at the University of Newcastle by Eleanor Majellano, under the supervision of Professor Vanessa McDonald and Dr Vanessa Clark. We are investigating the barriers, facilitators and attitudes of clinicians and allied healthcare professionals towards the optimal management of severe asthma in various healthcare settings.

Before you decide whether or not you wish to participate in this study, it is important for you to understand why the research is being conducted and what it will involve.

Please download the information and participation forms here if you are interested or would like to contact the investigators:

Participation Information Sheet.

This study has been approved by the Hunter New England Human Research Ethics Committee Reference. If you have concerns or complaints about the conduct of this study you should contact:

Dr. Nicole Gerrand

Manager

Research Ethics & Governance Office

Hunter New England Local Health District

   Email: HNELHD-HREC@health.nsw.gov.au

The manager is the person nominated to receive complaints from research participants.

You will need to quote reference number 2019/ETH00143.

 

Thank you for taking the time to consider this study.

If you wish to take part in it, please sign the attached consent form.

This information sheet is for you to keep.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

VOLUME 5.03 – APRIL 2020

VOLUME 4.05 JULY 2019

Research Roundup:

July 2019

.
 

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. The wheels have officially begun turning for our 2020 TSANZ ASM, which means a wide range of opportunities to submit abstracts and will be opening on 12 July! Please visit our TSANZSRS2020 website for more details about abstracts & TSANZ Travel Awards once the submission portal is live, and pay close attention to the closing dates.
For our registered nurses, don’t forget about the TSANZ Indigenous Respiratory Nursing Awards, which will help support the cost of attendance to the TSANZ ASM for those with indigenous heritage, or working with indigenous communities in respiratory health.

We have a few new Lung Foundation Australia awards opening this month, so see below for details. Applications are still open for LFA/A Menarini travel grants for ERS and APSR – if you are interested in attending be sure to send in your submissions before the deadline. We have also extended the date for the Brian Eaton IPF award.
If you are planning on attending the TSANZ New Zealand Annual Scientific Meeting, we still have travel grant applications open until 15 July so click here to apply now.

We would also like to bring to your attention the Bupa 2019 Emerging Health Researcher Awardnominations are open on their website. This award is designed for Early Career Researchers and the recipient will receive a prize of $25,000 to put towards further research. Selected Finalists and Highly Commended nominations will also be recognised.
icare also have opened their Dust Diseases Grant program to applicants, which closes 2 August. Please scroll down for more information on both.

We hope you enjoy the July edition of your Research Roundup!

 

Tanya Buchanan
(standing in for Sandra Hodge earning a well-earned break!)
CEO, The Thoracic Society of Australia and New Zealand

Open Awards

Thoracic Society Awards

TSANZ NZ ASM Travel Grants 2019 – closes 15th July 2019

TSANZ ASM 2020 abstract-linked Awards – closing 11 October 2019
(N.B. the submission portal will become live on July 12)

TSANZ Indigenous Respiratory Nursing Award – closes 30th October 2019

Lung Foundation Awards

LFA / Brian Eaton IPF PhD Scholarship – EXTENDED until 14 July 2019 

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

Travel application deadlines

ERS: 31st July 2019 (5pm AEST)

APSR: 13th September 2019 (5pm AEST)

N.B. The following awards will open 14 July

BI / COPD Research Fellowship – closes 25 August 2019

Lung Foundation Australia / Lizotte Family Research Award for IPF Research – closes 25 August 2019

LFA / Ludwig Engel Grant-In-Aid for Physiological Research – closes 25 August 2019

Ivan Cash Grant-In-Aid for IPF Research – closes 25 August 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

iCare Dust Diseases Grant Program

For all the application details, please visit https://www.icare.nsw.gov.au/injured-or-ill-people/work-related-dust-disease/research-and-funding/#gref.
If you have any questions or would like to know more about the program please contact: ddcgrants@icare.nsw.gov.au 

Bupa Health Foundation Emerging Health Researcher Award

The Bupa Health Foundation is seeking nominations for its 2019 Emerging Health Researcher Award.  

Nominations close on Monday 15th July 2019 (9AM AEST).

Award criteria and the nomination form can be found at https://www.bupa.com.au/about-us/bupa-health-foundation.

Should you have any queries, please contact Alana Fisher, Operations Manager, Bupa Health Foundation at foundation@bupa.com.au

_______________________________________________________________________________

Respirology – Editor’s Choice 

Respirology Issue 24.7 July 2019

Clinical usefulness of routine AFB culture and MTB PCR of EBUS‐TBNA needle rinse fluid

Ryoung-Eun Ko, Byeong-Ho Jeong, Hae Ri Chon, Hee Jae Huh, Joungho Han, Hyun Lee, Kyungjong Lee, Hojoong Kim, O. Jung Kwon, Sang-Won Um

 

Researchers from the Division of Pulmonary and Critical Care Medicine at the Samsung Medical Center in Seoul, South Korea. From left to right: Byoung-Ho Jeong, Sang-Won Um, and Ryoung-Eun Ko

DOI: 10.1111/resp.13488

 

Changes in physical activity during hospital admission for chronic respiratory disease

Mark W. Orme, Theresa C. Harvey-Dunstan, Ismet Boral, Emma J.L. Chaplin, S. Fayyaz Hussain, Mike D.L. Morgan, Michael C. Steiner, Sally J. Singh, Neil J. Greening

 

A single day of physical activity monitoring

DOI: 10.1111/resp.13513

Research Project and Survey Requests

 

What is “suspected” lung cancer?

Lung cancer is the leading cause of cancer-related mortality and morbidity in Australia. The Cancer Council’s Optimal Care Pathway suggests that patients with suspected lung cancer on CT scan be seen by a specialist within two weeks. But what exactly is “suspected” lung cancer? Does that 5mm lung nodule found incidentally on CT coronary angiogram need urgent specialist attention?

St John of God Healthcare doctors and Curtin University researchers are inviting respiratory physicians to help us define “suspected” lung cancer. We need you to review 10 short case scenarios and tell us if each of the patients should be seen by a specialist within two weeks.

To participate, click here.

You have been anonymously invited to participate because the Thoracic Society of Australia and New Zealand identifies you as a member. Consent is implied by your voluntary participation. This research study has been reviewed and given approval from the Curtin University and St John of God Healthcare Human Research Ethics Committees.
If you have questions or comments, you can contact the Principle Investigator on david.manners@sjog.org.au, the Curtin University HREC on hrec@curtin.edu.au or the SJOG Healthcare HREC on ethics@sjog.org.au.

 

Survey of Attitudes of Australian Specialists to Lung Cancer Screening with Low Dose Computed Tomography

To Members of the Thoracic Society of Australia and New Zealand,

Lung cancer screening with low dose computed tomography has been implemented overseas however is still a debated topic within Australia. We are conducting a survey of Australian specialists and their knowledge and attitudes towards lung cancer screening and perceived barriers to the implementation of lung cancer screening with low dose computed tomography within Australia.

The anonymous survey is available online using the SurveyMonkey survey tool and takes approximately 7 minutes to complete.  It can be accessed via the following link.  https://www.surveymonkey.com/r/AttitudesToLDCT

Please don’t hesitate to contact us if you require any further information.  We attach our study protocol and copy of HREC approval (The Prince Charles Hospital Human Research and Ethics Committee LNR/2018/QPCH/44970).

Thank you for your kind support.

Yours truly

Rachel McLellan, Advanced RACP Trainee
Kwun Fong
Henry Marshall
Rayleen Bowman
Ian Yang

University of Queensland Thoracic Research Centre at The Prince Charles Hospital
Metro North Hospital and Health Service | Queensland Government
Rode Road, Chermside, Brisbane QLD 4032, AUSTRALIA
t. 61 7 [31394000] e. ILST@health.qld.gov.au | www.health.qld.gov.au

 

 

New survey about Victorian doctors’ end-of-life decision-making

Victorian doctors in specialties likely to be involved in end-of-life decisions are being surveyed about their decision-making practices involving adult patients. Researchers from the NHMRC-funded Centre of Research Excellence in End-of-Life Care are conducting a study to determine what sort of end-of-life decisions are being made by doctors, how often these decisions occur and for what sort of patients.

At present, there are no up-to-date, representative Australian data describing the frequency and nature of medical end-of-life decisions involving adults, and the characteristics of patients about whom such decisions are made. The research aims to provide an evidence base to understand current medical practice in Victoria including the extent to which palliative care is provided to patients at the end of life. Findings from this research will also inform improvements in the quality of end-of-life care.

A sample of Victorian doctors will be contacted in April and May by the AMA’s Australia Medical Publishing Company (AMPCo) to invite them to complete a survey.  The survey can be completed in hard copy or online.  Participating doctors who complete their survey before 16 May will go into the draw for one of three prizes to the value $100, in fine wine, or a donation to a registered charity of your choice.

If you have any queries about this research, please feel free to contact Dr Rachel Feeney[rachel.feeney@qut.edu.au]. The research team is grateful for the time and insight of the doctors who support this research by completing this survey.

 

 

Genomic medicine here to stay? Have your say.

Are you a medical specialist in Australia?

If so, tell us your thoughts about genomic medicine
practice and continuing medical education!

We need to hear from non-genetic medical specialists
who work clinically in Australia.

We want to know about past, present and future aspects
of genetics and health, including genomics in healthcare.

It doesn’t matter how much you know about this,
or whether you incorporate genomics into your practice or not;
your opinions, views and experiences are valuable to us.

You will help shape future workforce practices and
continuing education and training programs

Click here to complete the anonymous 15-minute survey.
Please distribute this link to your networks

Please note there are separate studies for clinical geneticists, oncologists, pathologists, radiologists and general practitioners, who will be contacted directly.

This survey is an activity of the Workforce Development Program of the NH&MRC-funded
Australian Genomics Health Alliance. If you have any queries, please contact Dr Amy Nisselle, Specialist Project Officer, Australian Genomics Health Alliance (amy.nisselle@mcri.edu.au or 03 9936 6340).

This survey has HREC approval, The University of Melbourne (1646785.8).

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

VOLUME 5.03 – APRIL 2020

VOLUME 4.04 JUNE 2019

Research Roundup:

June 2019

.
 

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. At the 2019 ATS we saw plenty of important research being conducted across the respiratory field including methodological advances to improve airway wall measurement accuracy for patients with COPD, the importance of understanding haemoglobin biomarkers in patients presenting with COPD and anaemia, and the construction of a Pediatric Asthma Risk Score (PARS) to better predict asthma development in children. It’s not over yet though, as conference season is still in full swing with the ERS International Congress and APSR Congress being held in the coming months. Applications are still open for LFA/A Menarini travel grants for these two conferences, so if you are interested in attending be sure to send in your submissions before the deadline. We are also opening up applications for five (5) travel grants to attend the TSANZ New Zealand Annual Scientific Meeting, on 14-16 August 2019, so please click here for further information. 

Many of our research awards are closing this month, and we look forward to reviewing all of the submissions we received and wish best of luck to our applicants. Applications for the PACT Grant-In-Aid Funding Opportunity will remain open until 26 June, so check the Open Awards section below for further details regarding dates and guidelines.

We would also like to remind you that submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. If you have been trying to uncover some hidden academic riches locked away in the recesses of respiratory research, we want to hear about it! You will be featured in an upcoming Research Roundup and also published on the limbic website. This is a great opportunity to tell us about your research and inspiration, and provides a platform to be able to connect your passion project with our network of TSANZ members and the limbic subscribers. Details can be found here.

We hope you enjoy the June edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ NZ ASM Travel Grants 2019 – closes 15th July 2019

Lung Foundation Awards

Lung Foundation Australia Brian Eaton Memorial PhD Scholarship in IPF – closes 10th June 2019

Lung Foundation Australia Diana Cox PhD Scholarship in IPF – closes 10th June 2019

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

Travel application deadlines

ERS: 31st July 2019 (5pm AEST)

APSR: 13th September 2019 (5pm AEST)

PACT Grant-in-Aid Funding Opportunity – closes 26th June 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Lung Foundation Australia Board 

Expressions of Interest 

Lung Foundation Australia (LFA) is seeking expressions of interest for the appointment of new Board Directors, from individuals with a strong clinical or respiratory science interest who are members of TSANZ.  

Click here for more information on applying! 

If you are interested in this position, please see the above document regarding formal application, which should be made by email to Prof Christine Jenkins, Chair, Lung Foundation Australia, before 18th June 2019.

________________________________________________________________________________

Respirology – Editor’s Choice 

Respirology Issue 26.4 June 2019

Idiopathic chronic productive cough and response to open-label macrolide therapy: An observational study

Matthew J. Martin, Helen Lee, Carly Clayton, Kate Pointon, Irshad Soomro, Dominick E. Shaw and Tim W. Harrison

 

An overview of the study protocol

DOI: 10.1111/resp.13483

 

Therapeutic burden in interstitial lung disease: Lessons to learn

Yet H. Khor, Ian Glaspole and Nicole S.L. Goh

 

Research team from Melbourne, Australia: from left to right A/Prof Ian Glaspole, Dr Yet Hong Khor and Dr Nicole Goh

DOI: 10.1111/resp.13480

Research Project and Survey Requests

 

What is “suspected” lung cancer?

Lung cancer is the leading cause of cancer-related mortality and morbidity in Australia. The Cancer Council’s Optimal Care Pathway suggests that patients with suspected lung cancer on CT scan be seen by a specialist within two weeks. But what exactly is “suspected” lung cancer? Does that 5mm lung nodule found incidentally on CT coronary angiogram need urgent specialist attention?

St John of God Healthcare doctors and Curtin University researchers are inviting respiratory physicians to help us define “suspected” lung cancer. We need you to review 10 short case scenarios and tell us if each of the patients should be seen by a specialist within two weeks.

To participate, click here.

You have been anonymously invited to participate because the Thoracic Society of Australia and New Zealand identifies you as a member. Consent is implied by your voluntary participation. This research study has been reviewed and given approval from the Curtin University and St John of God Healthcare Human Research Ethics Committees.
If you have questions or comments, you can contact the Principle Investigator on david.manners@sjog.org.au, the Curtin University HREC on hrec@curtin.edu.au or the SJOG Healthcare HREC on ethics@sjog.org.au.

 

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Survey of Attitudes of Australian Specialists to Lung Cancer Screening with Low Dose Computed Tomography

To Members of the Thoracic Society of Australia and New Zealand,

Lung cancer screening with low dose computed tomography has been implemented overseas however is still a debated topic within Australia. We are conducting a survey of Australian specialists and their knowledge and attitudes towards lung cancer screening and perceived barriers to the implementation of lung cancer screening with low dose computed tomography within Australia.

The anonymous survey is available online using the SurveyMonkey survey tool and takes approximately 7 minutes to complete.  It can be accessed via the following link.  https://www.surveymonkey.com/r/AttitudesToLDCT

Please don’t hesitate to contact us if you require any further information.  We attach our study protocol and copy of HREC approval (The Prince Charles Hospital Human Research and Ethics Committee LNR/2018/QPCH/44970).

Thank you for your kind support.

Yours truly

Rachel McLellan, Advanced RACP Trainee
Kwun Fong
Henry Marshall
Rayleen Bowman
Ian Yang

University of Queensland Thoracic Research Centre at The Prince Charles Hospital
Metro North Hospital and Health Service | Queensland Government
Rode Road, Chermside, Brisbane QLD 4032, AUSTRALIA
t. 61 7 [31394000] e. ILST@health.qld.gov.au | www.health.qld.gov.au

 

 

New survey about Victorian doctors’ end-of-life decision-making

Victorian doctors in specialties likely to be involved in end-of-life decisions are being surveyed about their decision-making practices involving adult patients. Researchers from the NHMRC-funded Centre of Research Excellence in End-of-Life Care are conducting a study to determine what sort of end-of-life decisions are being made by doctors, how often these decisions occur and for what sort of patients.

At present, there are no up-to-date, representative Australian data describing the frequency and nature of medical end-of-life decisions involving adults, and the characteristics of patients about whom such decisions are made. The research aims to provide an evidence base to understand current medical practice in Victoria including the extent to which palliative care is provided to patients at the end of life. Findings from this research will also inform improvements in the quality of end-of-life care.

A sample of Victorian doctors will be contacted in April and May by the AMA’s Australia Medical Publishing Company (AMPCo) to invite them to complete a survey.  The survey can be completed in hard copy or online.  Participating doctors who complete their survey before 16 May will go into the draw for one of three prizes to the value $100, in fine wine, or a donation to a registered charity of your choice.

If you have any queries about this research, please feel free to contact Dr Rachel Feeney[rachel.feeney@qut.edu.au]. The research team is grateful for the time and insight of the doctors who support this research by completing this survey.

 

 

Genomic medicine here to stay? Have your say.

Are you a medical specialist in Australia?

If so, tell us your thoughts about genomic medicine
practice and continuing medical education!

We need to hear from non-genetic medical specialists
who work clinically in Australia.

We want to know about past, present and future aspects
of genetics and health, including genomics in healthcare.

It doesn’t matter how much you know about this,
or whether you incorporate genomics into your practice or not;
your opinions, views and experiences are valuable to us.

You will help shape future workforce practices and
continuing education and training programs

Click here to complete the anonymous 15-minute survey.
Please distribute this link to your networks

Please note there are separate studies for clinical geneticists, oncologists, pathologists, radiologists and general practitioners, who will be contacted directly.

This survey is an activity of the Workforce Development Program of the NH&MRC-funded
Australian Genomics Health Alliance. If you have any queries, please contact Dr Amy Nisselle, Specialist Project Officer, Australian Genomics Health Alliance (amy.nisselle@mcri.edu.au or 03 9936 6340).

This survey has HREC approval, The University of Melbourne (1646785.8).

.

VOLUME 5.03 – APRIL 2020

VOLUME 4.01 MARCH 2019

Research Roundup:

March 2019

.
 

Welcome Message

The TSANZSRS19 is just around the corner, coming up in just 3 short weeks! This year’s theme is respiratory infection and will showcase plenary sessions such as How infections and microbiomes influence respiratory disease, Microbial pathogenesis in chronic lung disease, and the ANZSRS/TSANZ joint plenary on Bugs behaving badly. The theme even extends into the TSANZ Gala Dinner, inviting delegates to come dressed as their choice of superhero or superbug! Visit the conference website for the full program or to register now.

We would like to remind everyone that this year we will once again be holding the Respiratory Research Excellence Awards and you are all invited and encouraged to attend! This event drew a full house last year as we all gathered to support, thank and congratulate our colleagues, collaborators, and sponsors. Please pick up a glass of bubbles at the door and join us again for this opening event.

We wish you all the best in your preparation for the ASM. See you on the Gold Coast.

Enjoy the March edition of your research roundup and please check out the surveys below.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

 

Open Awards

Lung Foundation Awards

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

Travel application deadlines

ATS: 22nd March 2019 (5pm AEST)

ERS: 31st July 2019 (5pm AEST)

APSR: 13th September 2019 (5pm AEST)

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issues 2019

Treatable traits can be identified in a severe asthma registry and predict future exacerbations

Vanessa M. McDonald, Sarah A. Hiles, Krystelle Godbout, Erin S. Harvey, Guy B. Marks, Mark Hew, Matthew Peters, Philip G. Bardin, Paul N. Reynolds, John W. Upham, Melissa Baraket, Zaheerodin Bhikoo, Jeffrey Bowden, Ben Brockway, Li Ping Chung, Belinda Cochrane, Gloria Foxley, Jeffrey Garrett, Lata Jayaram, Christine Jenkins, Constance Katelaris, Gregory Katsoulotos, Mariko S. Koh, Vicky Kritikos, Marina Lambert, David Langton, Alexis Lara Rivero, Peter G. Middleton, Aldoph Nanguzgambo, Naghmeh Radhakrishna, Helen Reddel, Janet Rimmer, Anne Marie Southcott, Michael Sutherland, Francis Thien, Peter A.B. Wark, Ian A. Yang, Elaine Yap, and Peter G. Gibson

DOI: 10.1111/resp.13389

 

 

Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis

Hee‐Young Yoon, Tae Hoon Kim, Joon Beom Seo, Sang Min Lee, Soyeoun Lim, Han Na Lee, Namkug Kim, Minkyu Han, Dong Soon Kim, and Jin Woo Song.

DOI: 10.1111/resp.13387

 

CT scans of a patient with IPF and 7.6% emphysema [LEFT], and a texture-based automated quantitative system classification denoting regional patterns of lung tissue [RIGHT], including normal (green), reticular opacity (cyan), emphysema (red), consolidation (pink) and honeycombing (blue).

 

Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis

Lurdes Planas‐Cerezales, Elena G. Arias‐Salgado, Ivette Buendia‐Roldán, Ana Montes‐Worboys, Cristina Esquinas López, Vanesa Vicens‐Zygmunt, Patricio Luburich Hernaiz, Roger Llatjós Sanuy, Virginia Leiro‐Fernandez, Eva Balcells Vilarnau, Ernest Sala Llinás, Jordi Dorca Sargatal, Rosario Perona Abellón, Moisés Selman, and Maria Molina‐Molina.

DOI: 10.1111/resp.13423

 

Transplant-free survival time according to the presence or absence of telomere shortening in combination of being younger or older than 60 years of age.

 

Pulmonary arterial hypertension in a multi-ethnic Asian population: Characteristics, survival and mortality predictors from a 14-year follow-up study

Yinghao Lim, Ting‐Ting Low, Siew‐Pang Chan, Ting Wei Teo, Jin‐Hao Justin Jang, Nicole Yip, Ivandito Kuntjoro, Edgar Lik‐Wui Tay, and James Wei‐Luen Yip.

DOI: 10.1111/resp.13392

 

The pulmonary hypertension team at the National University Heart Centre in Singapore; from left to right: Edgar Tay, Ivandito Kuntjoro, Justin Jang, Siew Pang Chan, Ting Ting Low, Geying Li, Ai Huong Then, Ting Wei Teo and Yinghao Lim. Missing from this photo are authors Nicole Yip and James Yip.

 

Understanding the patient’s experience of care in idiopathic pulmonary fibrosis

Kimberley Burnett, Ian Glaspole, and Anne E. Holland

DOI: 10.1111/resp.13414

 

The Alfred Hospital in Melbourne, Australia (Source: Public Affairs, The Alfred)

 

Choosing the right mask for your Asian patient with sleep apnoea: A randomized, crossover trial of CPAP interfaces

Ken Junyang Goh, Rui Ya Soh, Leong Chai Leow, Song Tar Toh, Pei Rong Song, Ying Hao, Ken Cheah Hooi Lee, Gan Liang Tan, and Thun How Ong.

DOI: 10.1111/resp.13396

 

Example of a CPAP therapy mask for patients with OSA

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 

.

VOLUME 5.03 – APRIL 2020

VOLUME 3.09 DECEMBER 2018

Research Roundup:

December 2018

.
 

Welcome Message

As the year draws to a close and many of us are wrapping up for the summer break we have a few short messages for you.

Firstly, we have two awards open which we would like to draw your attention to:

Secondly, late-breaking abstracts are open, so if you have any new work to share with your colleagues, please consider submitting to TSANZSRS19!

Lastly, we wish you all a safe and relaxing break over the festive season. For those who will remain at work, we hope all goes smoothly for you! Enjoy the December edition of your research roundup and please check out the surveys below.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 14 Feb 19

TSANZ Indigenous Respiratory Nursing Award – closes 31 Jan 19

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issue 23.12 (December 2018)

Inflammation-dependent and independent airway remodelling in asthma

John G. Elliot, Peter B. Noble, Thais Mauad, Tony R. Bai, Michael J. Abramson, Karen O. McKay, Francis H.Y. Green, Alan L. James

DOI: 10.1111/resp.13360

 

1000-fold magnification of the airway smooth muscle layer with a counting grid overlay for planimetry assessment of the airway smooth muscle area.

Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database

Canan Gündüz, Ozen K. Basoglu, Jan Hedner, Ding Zou, Maria R. Bonsignore, Holger Hein, Richard Staats, Athanasia Pataka, Ferran Barbe, Pavel Sliwinski, Brian D. Kent, Jean Lois Pepin, ​​​​​​​Ludger Grote, on behalf of the European Sleep Apnea Database Collaborators.

DOI: 10.1111/resp.13372

 

ESADA researchers and collaborators from left to right: Holger Hein, Sven Svedmyr, Ding Zou, Canan Gündüz, Ludger Grote.

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 

.

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X